Stapley Jacob N, Hamley Jonathan I D, Basáñez Maria-Gloria, Walker Martin
MRC Centre for Global Infectious Disease Analysis and London Centre for Neglected Tropical Disease Research, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London, United Kingdom.
Department of Visceral Surgery and Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
PLoS Comput Biol. 2025 Apr 21;21(4):e1013026. doi: 10.1371/journal.pcbi.1013026. eCollection 2025 Apr.
The World Health Organization (WHO) has proposed elimination of onchocerciasis transmission (EOT) in a third of endemic countries by 2030. This requires country-wide verification of EOT. Prior to the shift from morbidity control to EOT, interventions in Africa were mostly targeted at moderate- to high-transmission settings, where morbidity was most severe. Consequently, there remain numerous low transmission (hypoendemic) settings which have hitherto not received mass drug administration (MDA) with ivermectin. The WHO has prioritised the delineation of hypoendemic settings to ascertain treatment needs. However, the stability of transmission at such low levels remains poorly understood. We use the stochastic EPIONCHO-IBM transmission model to characterise the stability of transmission dynamics in hypoendemic settings and identify a range of threshold biting rates (TBRs, the annual vector biting rates below which transmission cannot be sustained). We show how TBRs are dependent on population size, inter-individual exposure heterogeneity and simulation time. In contrast with deterministic expectations, there is no fixed TBR; instead, transmission can persist between 70 and 300 bites/person/year. Using survivorship models on data generated from model simulations, we find that multiple vector biting rates can sustain hypoendemic prevalence for several decades. These findings challenge the assumption that hypoendemic foci would naturally fade out following treatment in nearby higher-endemicity regions. Our modelling suggests that, to achieve EOT, treatment should be extended to all areas where endogenous infection is identified, emphasising the need for improved diagnostic tools suitable for detecting low-prevalence infection and for strategies that allow safe treatment of communities where MDA would not be suitable.
世界卫生组织(WHO)提议到2030年在三分之一的流行国家消除盘尾丝虫病传播(EOT)。这需要在全国范围内对EOT进行核查。在从发病率控制转向EOT之前,非洲的干预措施大多针对中度至高度传播地区,这些地区的发病率最为严重。因此,仍有许多低传播(低度流行)地区迄今尚未接受伊维菌素大规模药物给药(MDA)。WHO已将划定低度流行地区作为优先事项,以确定治疗需求。然而,对于如此低水平传播的稳定性仍知之甚少。我们使用随机EPIONCHO-IBM传播模型来描述低度流行地区传播动态的稳定性,并确定一系列阈值叮咬率(TBR,即年度病媒叮咬率低于该值传播就无法持续)。我们展示了TBR如何取决于人口规模、个体间暴露异质性和模拟时间。与确定性预期相反,不存在固定的TBR;相反,传播可以在每人每年70至300次叮咬之间持续。使用基于模型模拟生成数据的生存模型,我们发现多种病媒叮咬率可以使低度流行患病率维持数十年。这些发现挑战了这样一种假设,即低度流行病灶在附近高流行地区接受治疗后会自然消失。我们的模型表明,为实现EOT,治疗应扩展到所有确定有内源性感染的地区,强调需要改进适用于检测低流行感染的诊断工具,以及需要制定策略,以便在MDA不适用的社区进行安全治疗。